Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
Κύριοι συγγραφείς: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
BioMed Central
2016
|
Παρόμοια τεκμήρια
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
ανά: Saunders, K, κ.ά.
Έκδοση: (2016) -
Older patients are eligible for trial of lithium and valproate.
ανά: Rendell, J, κ.ά.
Έκδοση: (2003) -
New trial should clarify lithium use in bipolar disorder.
ανά: Geddes, J, κ.ά.
Έκδοση: (2002) -
Lith6
ανά: Malcolm A. Lyons, κ.ά.
Έκδοση: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
ανά: Atkinson, L, κ.ά.
Έκδοση: (2019)